AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of products.

Half of the participants received a weekly injection of two milligrams of the drug exenatide, which is a GLP-1 receptor ...

Sharon Osbourne was pictured with Black Sabbath star Tony Iommi after it was announced the band was reuniting for 'the ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...